These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22232869)

  • 1. [Testosterone and prostate].
    Vaucher L; Paduch DA; Jichlinski P; Pralong F
    Rev Med Suisse; 2011 Dec; 7(320):2399-400, 2402-3. PubMed ID: 22232869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy in men with untreated prostate cancer.
    Morgentaler A; Lipshultz LI; Bennett R; Sweeney M; Avila D; Khera M
    J Urol; 2011 Apr; 185(4):1256-60. PubMed ID: 21334649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Barqawi A; Crawford ED
    Int J Impot Res; 2006; 18(4):323-8. PubMed ID: 16281043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and the aging male: to treat or not to treat?
    Bain J
    Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of testosterone in the pathogenesis of prostate cancer.
    Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T
    Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
    Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and prostate cancer: revisiting old paradigms.
    Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
    Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone supplementation and prostate cancer, controversies still exist.
    Drewa T; Chłosta P
    Acta Pol Pharm; 2010; 67(5):543-6. PubMed ID: 20873424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy and the risk of prostate cancer: a perspective view.
    Barqawi AB; Crawford ED
    Int J Impot Res; 2005; 17(5):462-3. PubMed ID: 15889127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible relationship between testosterone and lower urinary tract symptoms in men.
    Chang IH; Oh SY; Kim SC
    J Urol; 2009 Jul; 182(1):215-20. PubMed ID: 19447426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.